Introduction: Carbapenem resistance in Acinetobacter baumannii can be mediated by carbapenemases of class A, class B metallo-β-lactamases (MBLs), and class D carbapenem-hydrolyzing oxacillinases (CHDL). The aim of the study was to investigate the antimicrobial susceptibility and β-lactamase production of carbapenem-resistant A. baumannii isolates (CRAB) from the Children’s Hospital Zagreb, Croatia. Methods: A total of 12 A. baumannii isolates collected between August 2016 and March 2018 were analyzed. Antibiotic susceptibility was determined by the broth microdilution method. The presence of MBLs was explored by combined disk test with EDTA. The presence of carbapenemases of class A, B, and D was explored by PCR. The occurrence of the ISAba1 upstream of the blaOXA-51-like or blaOXA-23-like was determined by PCR mapping. Epidemiological typing was performed by determination of sequence groups (SG). Genotyping was performed by SG determination, rep-PCR, and MLST. Results: All CRAB were resistant to piperacillin/tazobactam, ceftazidime, cefotaxime, ceftriaxone, cefepime, imipenem, meropenem, gentamicin, and ciprofloxacin. Moderate resistance rates were observed for ampicillin/sulbactam (67%) and tigecycline (42%). The isolates were uniformly susceptible to colistin. PCR revealed the presence of genes encoding OXA-24-like CHDL in nine and OXA-23-like CHDL in three isolates. blaOXA-51 genes were preceded by ISAba1. PCR for the common MBLs in Acinetobacter was negative. All isolates belonged to SG 1 corresponding to ICL (International Clonal Lineage) II. Rep-PCR identified four major clones. Conclusions: The study found OXA-24-like β-lactamase to be the dominant CHDL among children’sCRAB. The predominant spread of OXA-24-like is in contrast with the recent global dissemination of OXA-23 reported all over the world. In contrast to the previous studies in which emergency of OXA-24-like positive isolates was monoclonal, we found considerable genetic diversity of the isolates.

1.
Coelho
J
,
Woodford
N
,
Turton
J
,
Livermore
DM
.
Multiresistant acinetobacter in the UK: how big a threat?
J Hosp Infect
.
2004
Nov
;
58
(
3
):
167
9
.
[PubMed]
0195-6701
2.
Brown
S
,
Amyes
S
.
OXA (β)-lactamases in Acinetobacter: the story so far
.
J Antimicrob Chemother
.
2006
Jan
;
57
(
1
):
1
3
.
[PubMed]
0305-7453
3.
Cornaglia
G
,
Riccio
ML
,
Mazzariol
A
,
Lauretti
L
,
Fontana
R
,
Rossolini
GM
.
Appearance of IMP-1 metallo-β-lactamase in Europe
.
Lancet
.
1999
Mar
;
353
(
9156
):
899
900
.
[PubMed]
0140-6736
4.
Hrabák
J
,
Stolbová
M
,
Studentová
V
,
Fridrichová
M
,
Chudáčková
E
,
Zemlickova
H
.
NDM-1 producing Acinetobacter baumannii isolated from a patient repatriated to the Czech Republic from Egypt, July 2011
.
Euro Surveill
.
2012
Feb
;
17
(
7
):
325
33
.
[PubMed]
1560-7917
5.
Perilli
M
,
Pellegrini
C
,
Celenza
G
,
Bellio
P
,
Segatore
B
,
Amicosante
G
.
First report from Italy of blaVIM-1 and blaTEM-1 genes in Pseudomonas putida and Acinetobacter baumannii isolated from wastewater
.
J Chemother
.
2011
Jun
;
23
(
3
):
181
2
.
[PubMed]
1120-009X
6.
Robledo
IE
,
Aquino
EE
,
Santé
MI
,
Santana
JL
,
Otero
DM
,
León
CF
, et al
Detection of KPC in Acinetobacter spp. in Puerto Rico
.
Antimicrob Agents Chemother
.
2010
Mar
;
54
(
3
):
1354
7
.
[PubMed]
0066-4804
7.
Poirel
L
,
Nordmann
P
.
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
.
Clin Microbiol Infect
.
2006
Sep
;
12
(
9
):
826
36
.
[PubMed]
1198-743X
8.
Goić-Barišić
I
,
Bedenić
B
,
Tonkić
M
,
Katić
S
,
Kalenić
S
,
Punda-Polić
V
.
First report of molecular characterization of carbapenem-resistant Acinetobacter baumannii in different intensive care units in University Hospital Split, Croatia
.
J Chemother
.
2007
Aug
;
19
(
4
):
462
4
.
[PubMed]
1120-009X
9.
Goić-Barišić
I
,
Bedenić
B
,
Tonkić
M
,
Novak
A
,
Katić
S
,
Kalenić
S
, et al
Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia
.
J Clin Microbiol
.
2009
Oct
;
47
(
10
):
3348
9
.
[PubMed]
0095-1137
10.
Franolić-Kukina
I
,
Bedenić
B
,
Budimir
A
,
Herljević
Z
,
Vraneš
J
,
Higgins
PG
.
Clonal spread of carbapenem-resistant OXA-72-positive Acinetobacter baumannii in a Croatian university hospital
.
Int J Infect Dis
.
2011
Oct
;
15
(
10
):
e706
9
.
[PubMed]
1201-9712
11.
Goić-Barišić
I
,
Towner
KJ
,
Kovačić
A
,
Šiško-Kraljević
K
,
Tonkić
M
,
Novak
A
, et al
Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase
.
J Hosp Infect
.
2011
Apr
;
77
(
4
):
368
9
.
[PubMed]
0195-6701
12.
Vranić-Ladavac
M
,
Bedenić
B
,
Minandri
F
,
Ištok
M
,
Bošnjak
Z
,
Frančula-Zaninović
S
, et al
Carbapenem resistance and acquired class D β-lactamases in Acinetobacter baumannii from Croatia 2009-2010
.
Eur J Clin Microbiol Infect Dis
.
2014
Mar
;
33
(
3
):
471
8
.
[PubMed]
0934-9723
13.
Bedenić
B
,
Beader
N
,
Godič-Torkar
K
,
Vranić-Ladavac
M
,
Luxner
J
,
Veir
Z
, et al
Nursing home as reservoir of carbapenem-resistant Acinetobacter baumannii
.
Microb Drug Resist
.
2015
Jun
;
21
(
3
):
270
8
.
[PubMed]
1076-6294
14.
Hrenović
J
,
Durn
G
,
Goić-Barišić
I
,
Kovačić
A
.
Occurrence of an environmental Acinetobacter baumannii strain similar to a clinical isolate in paleosol from Croatia
.
Appl Environ Microbiol
.
2014
May
;
80
(
9
):
2860
6
.
[PubMed]
0099-2240
15.
Hrenović
J
,
Goić-Barišić
I
,
Kazazic
S
,
Kovačić
A
,
Ganjto
M
,
Tonkić
M
.
Carbapenem-resistant isolates of Acinetobacter baumannii in a municipal wastewater treatment plant, Croatia, 2014
.
Euro Surveill
.
2016
Apr
;
21
(
15
):
30195
.
[PubMed]
1025-496X
16.
Hrenović
J
,
Durn
G
,
Music
MS
,
Dekić
S
,
Troskot-Čorbić
T
,
Škorić
D
.
Extensively and multi drug-resistant Acinetobacter baumannii recovered from technosol at a dump site in Croatia
.
Sci Total Environ
.
2017
Dec
;
607-608
:
1049
55
.
[PubMed]
0048-9697
17.
Clinical and Laboratory Standards Institute
. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement, M100-S18. Wayne, PA: CLSI;
2016
.
18.
Pournaras
S
,
Markogiannakis
A
,
Ikonomidis
A
,
Kondyli
L
,
Bethimouti
K
,
Maniatis
AN
, et al
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit
.
J Antimicrob Chemother
.
2006
Mar
;
57
(
3
):
557
61
.
[PubMed]
0305-7453
19.
Lee
K
,
Lim
YS
,
Yong
D
,
Yum
JH
,
Chong
Y
.
Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp
.
J Clin Microbiol
.
2003
Oct
;
41
(
10
):
4623
9
.
[PubMed]
0095-1137
20.
Pournaras
S
,
Maniati
M
,
Spanakis
N
,
Ikonomidis
A
,
Tassios
PT
,
Tsakris
A
, et al
Spread of efflux pump-overexpressing, non-metallo-β-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity
.
J Antimicrob Chemother
.
2005
Oct
;
56
(
4
):
761
4
.
[PubMed]
0305-7453
21.
Magiorakos
AP
,
Srinivasan
A
,
Carey
RB
,
Carmeli
Y
,
Falagas
ME
,
Giske
CG
, et al
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
.
Clin Microbiol Infect
.
2012
Mar
;
18
(
3
):
268
81
.
[PubMed]
1198-743X
22.
Poirel
L
,
Walsh
TR
,
Cuvillier
V
,
Nordmann
P
.
Multiplex PCR for detection of acquired carbapenemase genes
.
Diagn Microbiol Infect Dis
.
2011
May
;
70
(
1
):
119
23
.
[PubMed]
0732-8893
23.
Woodford
N
,
Ellington
MJ
,
Coelho
JM
,
Turton
JF
,
Ward
ME
,
Brown
S
, et al
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp
.
Int J Antimicrob Agents
.
2006
Apr
;
27
(
4
):
351
3
.
[PubMed]
0924-8579
24.
Arlet
G
,
Brami
G
,
Décrè
D
,
Flippo
A
,
Gaillot
O
,
Lagrange
PH
, et al
Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases
.
FEMS Microbiol Lett
.
1995
Dec
;
134
(
2-3
):
203
8
.
[PubMed]
0378-1097
25.
Nüesch-Inderbinen
MT
,
Hächler
H
,
Kayser
FH
.
Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test
.
Eur J Clin Microbiol Infect Dis
.
1996
May
;
15
(
5
):
398
402
.
[PubMed]
0934-9723
26.
Woodford
N
,
Ward
ME
,
Kaufmann
ME
,
Turton
J
,
Fagan
EJ
,
James
D
, et al
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK
.
J Antimicrob Chemother
.
2004
Oct
;
54
(
4
):
735
43
.
[PubMed]
0305-7453
27.
Pagani
L
,
Mantengoli
E
,
Migliavacca
R
,
Nucleo
E
,
Pollini
S
,
Spalla
M
, et al
Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase in Northern Italy
.
J Clin Microbiol
.
2004
Jun
;
42
(
6
):
2523
9
.
[PubMed]
0095-1137
28.
Bonnin
RA
,
Nordmann
P
,
Potron
A
,
Lecuyer
H
,
Zahar
JR
,
Poirel
L
.
Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii
.
Antimicrob Agents Chemother
.
2011
Jan
;
55
(
1
):
349
54
.
[PubMed]
0066-4804
29.
Turton
JF
,
Ward
ME
,
Woodford
N
,
Kaufmann
ME
,
Pike
R
,
Livermore
DM
, et al
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
.
FEMS Microbiol Lett
.
2006
May
;
258
(
1
):
72
7
.
[PubMed]
0378-1097
30.
Elwell
LP
,
Falkow
S
. The characterization of R plasmids and the detection of plasmid-specified genes. In:
Lorian
V
, editor
.
Antibiotics in Laboratory Medicine
. 2nd ed.
Baltimore (MD)
:
Williams and Wilkins
;
1986
. pp.
683
721
.
31.
Bertini
A
,
Poirel
L
,
Mugnier
PD
,
Villa
L
,
Nordmann
P
,
Carattoli
A
.
Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii
.
Antimicrob Agents Chemother
.
2010
Oct
;
54
(
10
):
4168
77
.
[PubMed]
0066-4804
32.
Turton
JF
,
Gabriel
SN
,
Valderrey
C
,
Kaufmann
ME
,
Pitt
TL
.
Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii
.
Clin Microbiol Infect
.
2007
Aug
;
13
(
8
):
807
15
.
[PubMed]
1198-743X
33.
Overdevest
IT
,
Willemsen
I
,
Elberts
S
,
Verhulst
C
,
Rijnsburger
M
,
Savelkoul
P
, et al
Evaluation of the DiversiLab typing method in a multicenter study assessing horizontal spread of highly resistant gram-negative rods
.
J Clin Microbiol
.
2011
Oct
;
49
(
10
):
3551
4
.
[PubMed]
0095-1137
34.
Bou
G
,
Oliver
A
,
Martínez-Beltrán
J
.
OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain
.
Antimicrob Agents Chemother
.
2000
Jun
;
44
(
6
):
1556
61
.
[PubMed]
0066-4804
35.
Lolans
K
,
Rice
TW
,
Munoz-Price
LS
,
Quinn
JP
.
Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40
.
Antimicrob Agents Chemother
.
2006
Sep
;
50
(
9
):
2941
5
.
[PubMed]
0066-4804
36.
Nemec
A
,
Krízová
L
,
Maixnerová
M
,
Diancourt
L
,
van der Reijden
TJ
,
Brisse
S
, et al
Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II
.
J Antimicrob Chemother
.
2008
Sep
;
62
(
3
):
484
9
.
[PubMed]
0305-7453
37.
Todorova
B
,
Velinov
T
,
Ivanov
I
,
Dobreva
E
,
Kantardjiev
T
.
First detection of OXA-24 carbapenemase-producing Acinetobacter baumannii isolates in Bulgaria
.
World J Microbiol Biotechnol
.
2014
Apr
;
30
(
4
):
1427
30
.
[PubMed]
0959-3993
38.
Petrović
T
,
Uzunović
S
,
Barišić
I
,
Luxner
J
,
Grisold
A
,
Zarfel
G
, et al
Arrival of carbapenem-hydrolyzing-oxacillinases in Acinetobacter baumannii in Bosnia and Herzegovina
.
Infect Genet Evol
.
2018
Mar
;
58
:
192
8
.
[PubMed]
1567-1348
39.
Dortet
L
, BonNin RA, Bernbeu S, Escaut L, Vittecoq D, Girlich D, et al. First occurrence of OXA-72-producing Acinetobacter baumannii in Serbia. Antimicrob Agents Chemother.
2016
;23:60(10):5724-30.
40.
Towner
KJ
,
Levi
K
,
Vlassiadi
M
;
ARPAC Steering Group
.
Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe
.
Clin Microbiol Infect
.
2008
Feb
;
14
(
2
):
161
7
.
[PubMed]
1198-743X
41.
Coelho
JM
,
Turton
JF
,
Kaufmann
ME
,
Glover
J
,
Woodford
N
,
Warner
M
, et al
Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England
.
J Clin Microbiol
.
2006
Oct
;
44
(
10
):
3623
7
.
[PubMed]
0095-1137
42.
Zong
Z
,
Lu
X
,
Valenzuela
JK
,
Partridge
SR
,
Iredell
J
.
An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 β-lactamase
.
Int J Antimicrob Agents
.
2008
;
31
(
1
):
50
4
.
[PubMed]
0924-8579
43.
Vilalon
P
,
Valdezeteb
S
,
Medina-Pascual
MJ
,
Curasco
G
,
Vindel
A
,
Saez-Nieto
JA
.
Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolyzing oxacillinase and metallo-β-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii
.
J Antimicrob Chemother
.
2011
;
68
(
3
):
550
3
. 0305-7453
44.
Ladavac
R
,
Bedenić
B
,
Vranić-Ladavac
M
,
Barišić
N
,
Karčić
N
,
Pompe
K
, et al
Emergence of different Acinetobacter baumannii clones in a Croatian hospital and cerrelation with antibiotic susceptibility. J Glob Antimicrob Resist.
2017
;10:213-218. doi: 10.1016
45.
Junyan
Q
,
Yu
D
,
Rujia
Y
,
Xiaoju
L
.
The first uutbreak caused by Acinetobacter baumannii ST208 and ST195 in China
.
BioMed Res Int
.
2016
;
2016
(
2
):
1
6
. 2314-6133
46.
Krizova
L
,
Poirel
L
,
Nordmann
P
,
Nemec
A
.
TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
.
J Antimicrob Chemother
.
2013
Dec
;
68
(
12
):
2786
91
.
[PubMed]
0305-7453
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.